News about Global Pharma

SOMAI Pharmaceuticals Receives EU-GMP Certification at Lisbon Facility

SOMAÍ also announced that it had raised €5 million to fund its activities.

Global Pharma | 06/09/2023 | By Manvi |  1186

Element Unveils Fully Integrated Pharma Services Platform

The strategic initiative brings together the capabilities of its recent North American acquisitions of Nanosyn and JMI labs into its existing life sciences business.

Global Pharma | 06/09/2023 | By Manvi |  853

Enzene Biosciences Inaugrates R&D Centre with Open Lab Setup in Pune

Enzene Biosciences Ltd. announced the inauguration of its research and development (R&D) facility in Pune.

Global Pharma | 05/09/2023 | By Manvi |  1094

Cipla Medpro South Africa Pty Ltd to Acquire Actor Pharma

This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities and leverage cost synergies in the South African market.

Global Pharma | 05/09/2023 | By Manvi |  681

Caplin Steriles Gets Establishment Inspection Report from US FDA

The unit underwent an inspection from US FDA and the inspection classification was determined by the agency as Voluntary Action Indicated (VAI).

Global Pharma | 05/09/2023 | By Manvi |  1085

Nottingham Researchers Gets Major Funds for Sustainable Pharma Manufacturing

Researchers from the University of Nottingham have joined forces with biotechnology company HydRegen for a project that will unlock sustainable biocatalytic hydrogenation – allowing the process to be scaled up and improved for industry use.

Global Pharma | 04/09/2023 | By Manvi |  704

Shilpa Pharma Lifesciences Ltd, Unit II Cleares GMP inspection by PMDA in Karnataka

The facility is involved in manufacturing various oncology and non?oncology APIs.

Global Pharma | 04/09/2023 | By Manvi |  1755

Biocon Acquires Manufacturing Facility of Eywa Pharma

The facility is acquired for a total consideration of US $7.7 million.

Global Pharma | 04/09/2023 | By Manvi |  1136

Delegation from HHS and FDA Visit Amneal Manufacturing Site in India

The visit followed the G20 Health Ministers' meeting in Gandhinagar, India, where health ministers from around the world met to discuss global health issues.

Global Pharma | 01/09/2023 | By Manvi |  1251

Zydus Receives Final Approval from USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg (RLD: Accutane® Capsules, 10 mg, 20 mg and 40 mg: RS: Claravis 10 mg, 20 mg, 30 mg and 40 mg).

Global Pharma | 01/09/2023 | By Manvi |  829